About HS Code 300241
This critical HS code covers vaccines, toxins, and cultures of micro-organisms specifically prepared for human medicine. It represents a cornerstone of global public health and disease prevention. The trade in these products is characterized by immense strategic importance, especially during pandemics or widespread disease outbreaks. Importers are typically national governments, public health organizations (like WHO, UNICEF), and pharmaceutical distributors, all focused on securing supplies for immunization programs. Exporters are a relatively small number of large pharmaceutical companies and specialized vaccine manufacturers with advanced research, development, and manufacturing capabilities. Key aspects of this trade include stringent regulatory approval, complex cold chain logistics, ethical considerations, and often, significant government procurement and subsidies. The market is highly sensitive to global health crises and public health policies.
Products Under This Code
Influenza vaccines, COVID-19 vaccines, Measles-Mumps-Rubella (MMR) vaccine, Polio vaccine, Tetanus vaccine, Diphtheria vaccine, HPV vaccine, Hepatitis B vaccine
Real World Examples
Pfizer-BioNTech COVID-19 Vaccine, Moderna COVID-19 Vaccine, AstraZeneca COVID-19 Vaccine, Gardasil (HPV vaccine), Fluzone (influenza vaccine), MMR-II (measles, mumps, rubella vaccine)
Common Misclassification
This code is specifically for human vaccines and related products, distinguishing it from 300242 which covers veterinary vaccines. It can also be confused with 300214 or 300215 if the product is an immunological preparation but not a vaccine.
Products Classified Under 3002.41
Industry
This code belongs to the Chemicals industry.
Trade Overview
India, Belgium, Germany, and the USA are major global producers and exporters of human vaccines.
Frequently Asked Questions
What is HS code 300241?
HS code 300241 covers: Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; for human medicine. This critical HS code covers vaccines, toxins, and cultures of micro-organisms specifically prepared for human medicine. It represents a cornerstone of global public health and disease prevention. The trade in these products is characterized by immense strategic importance, especially during pandemics or widespread disease outbreaks. Importers are typically national governments, public health organizations (like WHO, UNICEF), and pharmaceutical distributors, all focused on securing supplies for immunization programs. Exporters are a relatively small number of large pharmaceutical companies and specialized vaccine manufacturers with advanced research, development, and manufacturing capabilities. Key aspects of this trade include stringent regulatory approval, complex cold chain logistics, ethical considerations, and often, significant government procurement and subsidies. The market is highly sensitive to global health crises and public health policies.
What products fall under HS code 300241?
Influenza vaccines, COVID-19 vaccines, Measles-Mumps-Rubella (MMR) vaccine, Polio vaccine, Tetanus vaccine, Diphtheria vaccine, HPV vaccine, Hepatitis B vaccine
What are common misclassifications for HS code 300241?
This code is specifically for human vaccines and related products, distinguishing it from 300242 which covers veterinary vaccines. It can also be confused with 300214 or 300215 if the product is an immunological preparation but not a vaccine.
How is HS code 300241 structured?
HS code 300241 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (02) identify the heading, and digits 5-6 (41) specify the subheading. This code is standardized globally by the World Customs Organization.